These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23850924)

  • 1. New treatment strategies for pulmonary arterial hypertension: hopes or hypes?
    Galiè N; Manes A
    J Am Coll Cardiol; 2013 Sep; 62(12):1101-1102. PubMed ID: 23850924
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).
    Chen SL; Zhang FF; Xu J; Xie DJ; Zhou L; Nguyen T; Stone GW
    J Am Coll Cardiol; 2013 Sep; 62(12):1092-1100. PubMed ID: 23850902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo.
    Chen SL; Zhang YJ; Zhou L; Xie DJ; Zhang FF; Jia HB; Wong SS; Kwan TW
    EuroIntervention; 2013 Jun; 9(2):269-76. PubMed ID: 23466961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.
    Liu C; Jiang XM; Zhang J; Li B; Li J; Xie DJ; Hu ZY
    BMC Cardiovasc Disord; 2016 Oct; 16(1):192. PubMed ID: 27724864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Artery Denervation by Determining Targeted Ablation Sites for Treatment of Pulmonary Arterial Hypertension.
    Fujisawa T; Kataoka M; Kawakami T; Isobe S; Nakajima K; Kunitomi A; Kashimura S; Katsumata Y; Nishiyama T; Kimura T; Nishiyama N; Aizawa Y; Murata M; Fukuda K; Takatsuki S
    Circ Cardiovasc Interv; 2017 Oct; 10(10):. PubMed ID: 29042401
    [No Abstract]   [Full Text] [Related]  

  • 6. Arterial denervation: clinical implications and future perspectives.
    Stefanadis C
    Hellenic J Cardiol; 2013; 54(5):339-40. PubMed ID: 24100175
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter by Hoeper and Galiè Regarding Article, "Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes: Phase II Results From the Pulmonary Artery Denervation-1 Study".
    Hoeper MM; Galiè N
    Circ Cardiovasc Interv; 2016 Jan; 9(1):e003422. PubMed ID: 26755573
    [No Abstract]   [Full Text] [Related]  

  • 8. Beneficial Effects of Renal Denervation on Pulmonary Vascular Remodeling in Experimental Pulmonary Artery Hypertension.
    Qingyan Z; Xuejun J; Yanhong T; Zixuan D; Xiaozhan W; Xule W; Zongwen G; Wei H; Shengbo Y; Congxin H
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):562-70. PubMed ID: 25804321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Artery Denervation for Pulmonary Artery Hypertension.
    Rubin LJ
    JACC Cardiovasc Interv; 2015 Dec; 8(15):2024-2025. PubMed ID: 26738674
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary artery denervation for pulmonary arterial hypertension.
    Constantine A; Dimopoulos K
    Trends Cardiovasc Med; 2021 May; 31(4):252-260. PubMed ID: 32413394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous treatment of chronic thromboembolic pulmonary hypertension (CTEPH).
    Muller DW; Liebetrau C
    EuroIntervention; 2016 May; 12 Suppl X():X35-X43. PubMed ID: 27174110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial Commentary: Pulmonary Artery Denervation for Pulmonary Hypertension: Recent Updates and Future Perspectives.
    Razee A; Umar S
    Trends Cardiovasc Med; 2021 May; 31(4):261-263. PubMed ID: 32434044
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to Letter Regarding Article, "Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes: Phase II Results From the Pulmonary Artery Denervation-1 Study".
    Chen SL; Zhang H; Xie DJ; Zhang J; Zhou L; Rothman AM; Stone GW
    Circ Cardiovasc Interv; 2016 Jan; 9(1):e003463. PubMed ID: 26755574
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental pulmonary hypertension produced by surgical and chemical denervation of the pulmonary vasculature.
    Juratsch CE; Jengo JA; Castagna J; Laks MM
    Chest; 1980 Apr; 77(4):525-30. PubMed ID: 7357977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-based therapies for patients with medication-refractory pulmonary arterial hypertension.
    Leopold JA
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e003332. PubMed ID: 26553702
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulation Mapping of the Pulmonary Artery for Denervation Procedures: an Experimental Study.
    Condori Leandro HI; Vakhrushev AD; Goncharova NS; Korobchenko LE; Koshevaya EG; Mitrofanova LB; Andreeva EM; Moiseeva OM; Lebedev DS; Mikhaylov EN
    J Cardiovasc Transl Res; 2021 Jun; 14(3):546-555. PubMed ID: 33111219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter by Kuebler and Friedberg Regarding Article, "Pulmonary Artery Denervation by Determining Targeted Ablation Sites for Treatment of Pulmonary Arterial Hypertension".
    Kuebler WM; Friedberg MK
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e006148. PubMed ID: 29371213
    [No Abstract]   [Full Text] [Related]  

  • 18. Response by Fujisawa et al to Letter Regarding Article, "Pulmonary Artery Denervation by Determining Targeted Ablation Sites for Treatment of Pulmonary Arterial Hypertension".
    Fujisawa T; Kataoka M; Kawakami T; Isobe S; Nakajima K; Kunitomi A; Kashimura S; Katsumata Y; Nishiyama T; Kimura T; Nishiyama N; Aizawa Y; Murata M; Fukuda K; Takatsuki S
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e006244. PubMed ID: 29371214
    [No Abstract]   [Full Text] [Related]  

  • 19. An Ovine Model for Percutaneous Pulmonary Artery Laser Denervation: Perivascular Innervation and Ablation Lesion Characteristics.
    Condori Leandro HI; Koshevaya EG; Mitrofanova LB; Vakhrushev AD; Goncharova NS; Korobchenko LE; Andreeva EM; Lebedev DS; Mikhaylov EN
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thoracic bilateral sympathectomy as a new method of pulmonary arterial hypertension treatment: gaps of evidence.
    Travin N; Dalinin V; Salimov D
    Eur J Cardiothorac Surg; 2022 May; 61(6):1346-1347. PubMed ID: 35026003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.